Employee perceptions and experiences with tirzepatide treatment for obesity or overweight in the US: Insights from the PERCEPTIONS Survey.

Gibble TH, Al-Zubeidi T, Gerber C, Collins E, Vardavoulia A, Lin A, He X, Shepherd M, Fitch A, Bays H

Open source

DOI
10.1016/j.obpill.2026.100298
Published
2026 Sep
Container
Obesity pillars
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.obpill.2026.100298,
  title = {Employee perceptions and experiences with tirzepatide treatment for obesity or overweight in the US: Insights from the PERCEPTIONS Survey.},
  author = {Gibble TH and Al-Zubeidi T and Gerber C and Collins E and Vardavoulia A and Lin A and He X and Shepherd M and Fitch A and Bays H},
  year = {2026},
  journal = {Obesity pillars},
  doi = {10.1016/j.obpill.2026.100298},
  url = {https://doi.org/10.1016/j.obpill.2026.100298}
}

RIS

TY  - JOUR
TI  - Employee perceptions and experiences with tirzepatide treatment for obesity or overweight in the US: Insights from the PERCEPTIONS Survey.
AU  - Gibble TH
AU  - Al-Zubeidi T
AU  - Gerber C
AU  - Collins E
AU  - Vardavoulia A
AU  - Lin A
AU  - He X
AU  - Shepherd M
AU  - Fitch A
AU  - Bays H
PY  - 2026
JO  - Obesity pillars
DO  - 10.1016/j.obpill.2026.100298
UR  - https://doi.org/10.1016/j.obpill.2026.100298
ER  - 

APA

TH, G., T, A., C, G., E, C., A, V., A, L., X, H., M, S., A, F., & H, B. (2026). Employee perceptions and experiences with tirzepatide treatment for obesity or overweight in the US: Insights from the PERCEPTIONS Survey.. Obesity pillars. https://doi.org/10.1016/j.obpill.2026.100298

Source records